My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Substances
YK-11

YK-11

A-Z
Search for:
YK11
Deus Medical
YK11
Pharmaqo Labs
Intex Myostine
Intex Pharma
Myostane
Driada Medical
YK11
Baboon Pharma
YK 11
Dragon Pharma
Substance Overview and History

YK11, a steroidal SARM, was discovered in 2011 by Kanno’s team. Unlike traditional SARMs, it has a steroid-based structure, allowing unique interaction with androgen receptors. It functions as a partial receptor activator, minimizing typical androgenic responses while promoting muscle growth. YK11 also enhances follistatin levels, which helps inhibit myostatin, further supporting muscle hypertrophy. Its dual role in androgen activity and myostatin suppression makes it notable for research and athletic enhancement.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For more details consult with your doctor or healthcare professional.

FAQ
What is YK11?
YK11 is a steroidal selective androgen receptor modulator (SARM) that promotes muscle growth through partial activation of androgen receptors and increased follistatin levels.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

How does YK11 differ from other SARMs?
Unlike most non steroidal SARMs, YK11 has a steroid-based structure, offering unique interaction with androgen receptors and a different mechanism of action.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

What effects does YK11 have on muscle growth?
YK11 improves muscle development by binding to androgen receptors and increasing follistatin, which inhibits myostatin a protein that limits muscle growth.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.